Sastasundar Ventures Quarterly Results
Sastasundar Ventures quarterly results. In Sept 2025, Sastasundar Ventures (SASTASUNDR) reported revenue ₹307 Cr and net profit ₹-15 Cr — revenue +3.7% YoY. Check SASTASUNDR company valuation to track the company's total market size over time.
SASTASUNDR Quarterly Results — Revenue, Profit & EPS Highlights
Sastasundar Ventures latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review SASTASUNDR earnings valuation to evaluate earnings-based valuation against sector peers.
- Revenue of ₹307 Cr in Sept 2025 (-0.3% vs Mar 2025, +3.7% vs Sept 2024)
- Net Profit of ₹-15 Cr in Sept 2025 (-183.3% vs Mar 2025, +90.3% vs Sept 2024)
- EBITDA of ₹-17 Cr in Sept 2025 (-466.7% vs Mar 2025)
- Operating Margin of -8.0% in Sept 2025 (+1.0pp vs Mar 2025)
- Earnings Per Share of ₹-3.99 in Sept 2025 (-192.8% vs Mar 2025)
Sastasundar Ventures Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SASTASUNDR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 307 | 308 | 324 | 359 | 296 | -0.3% | 3.7% |
| Net Profit (₹ Cr) | -15 | 18 | 27 | 0 | -155 | - | - |
| EBITDA (₹ Cr) | -17 | -3 | 31 | 3 | -172 | - | - |
| EPS (₹) | -3.99 | 4.30 | 7.52 | 0.35 | -34.40 | - | - |
| Operating Margin (%) | -8.0% | -9.0% | 2.0% | -3.0% | -71.0% | - | - |
SASTASUNDR Share Price Trend — 1-Year Movement Across Quarterly Results
Sastasundar Ventures 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Sastasundar Ventures screener.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SASTASUNDR vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Sastasundar Ventures latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹116,947.25 Cr | 7985.0 | 6,660 | 551 | -6.3% | - | 8.3% | 216.9 |
|
Max Healthcare Inst…
Mar 2026 |
₹87,841.25 Cr | 917.0 | 2,191 | 342 | -9.0% | - | 15.6% | 260.5 |
|
Fortis Healthcare
Mar 2026 |
₹57,663.70 Cr | 763.8 | 2,375 | 271 | -7.7% | - | 11.4% | 217.0 |
|
Aster DM Healthcare
Mar 2026 |
₹42,146.56 Cr | 691.5 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 254.2 |
|
Global Health
Mar 2026 |
₹38,047.48 Cr | 1332.6 | 1,196 | 142 | -9.8% | - | 11.9% | 248.6 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores